FDA recalls Abbott’s HeartMate 3 due to potential malfunction
The US Food and Drug Administration (FDA) has issued a Class I Recall of Abbott’s HeartMate 3 Left…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 May 18
The US Food and Drug Administration (FDA) has issued a Class I Recall of Abbott’s HeartMate 3 Left…
24 May 18
UK start-up Ultromics has secured £10m funding to advance the commercialization of artificial intelligence (AI) technology for the…
22 May 18
Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has secured 510(k) clearance from the US Food…
17 May 18
Venus Medtech has secured equity investment from DCP Capital to speed up heart valve technology development and international…
17 May 18
Venus Medtech has secured equity investment from DCP Capital to speed up heart valve technology development and international…
15 May 18
Ancora Heart has expanded enrollment of US early feasibility study for the AccuCinch System for left ventricular repair.
15 May 18
In vitro diagnostic technologies provider Surmodics has agreed to acquire thrombectomy technology assets from Embolitech to strengthen peripheral…
15 May 18
In vitro diagnostic technologies provider Surmodics has agreed to acquire thrombectomy technology assets from Embolitech to strengthen peripheral…
12 May 18
Boston Scientific has announced real-world data demonstrating success of SMART Pass On The S-ICD system, highlighting reduction in…
12 May 18
A new study demonstrated feasibility of mechanical sensor in Medtronic Micra Transcatheter pacing system to identify atrial contractions…